Surfactant protein D and its oligomeric forms in chronic obstructive pulmonary disease

S. Lyamina, S. Kalish, I. Malyshev (Moscow, Russian Federation)

Source: Annual Congress 2013 –COPD: new markers of diseases
Session: COPD: new markers of diseases
Session type: Thematic Poster Session
Number: 597
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Lyamina, S. Kalish, I. Malyshev (Moscow, Russian Federation). Surfactant protein D and its oligomeric forms in chronic obstructive pulmonary disease. Eur Respir J 2013; 42: Suppl. 57, 597

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
HNP and CCSP protein levels are differentially regulated in BAL from patients with obstructive and restrictive chronic allograft dysfunctions
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015

Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid
Source: Eur Respir J 2004; 24: 964-970
Year: 2004



Profiling the proteome of the lower airway respiratory tract lining fluid in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013


Cellular composition of bronchoalveolar lavage (BAL) as inflammation indicator in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology
Year: 2014


Pulmonary and systemic inflammation in patients with AECOPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Is there any correlation between apoptosis of the cells from bronchoalveolar lavage fluid (BALF) and the progression of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

Sampling the lung fluids: peripheral biomarkers
Source: Annual Congress 2007 - Pulmonary biomarkers in COPD
Year: 2007


Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - What's new in tobacco and lung disease
Year: 2005


Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema
Source: Eur Respir J 2005; 25: 275-281
Year: 2005



The dynamics of IV-type collagen contens in balf of patients with chronic bronchitis and chronic bronchitis complicated with secondary bronchiectasis
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015


Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Serum surfactant protein D: Biomarker of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012

Galactomannans in bronchoalveolar lavage of patients with Idiopathic Pulmonary Fibrosis (IPF): a possible marker of disease progression.
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Airway dendritic cell phenotypes in inflammatory diseases of the human lung
Source: Eur Respir J 2007; 30: 878-886
Year: 2007



The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015


Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014

Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPD
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015